172 related articles for article (PubMed ID: 24090323)
1. The burden of chronic hepatitis B virus infection in Australia, 2011.
MacLachlan JH; Allard N; Towell V; Cowie BC
Aust N Z J Public Health; 2013 Oct; 37(5):416-22. PubMed ID: 24090323
[TBL] [Abstract][Full Text] [Related]
2. The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
Allard NL; MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2015 Jun; 39(3):255-9. PubMed ID: 25716519
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B status in migrants and refugees: increasing health burden in Western Australia.
Subramaniam K; Flexman J; Tarquinio L; Thambiran A; Hopkins S; Cheng W
Intern Med J; 2012 Aug; 42(8):880-6. PubMed ID: 22212294
[TBL] [Abstract][Full Text] [Related]
4. Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology.
MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2018 Oct; 42(5):441-443. PubMed ID: 30198602
[TBL] [Abstract][Full Text] [Related]
5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
6. Improving the identification of priority populations to increase hepatitis B testing rates, 2012.
van Gemert C; Wang J; Simmons J; Cowie B; Boyle D; Stoove M; Enright C; Hellard M
BMC Public Health; 2016 Feb; 16():95. PubMed ID: 26832144
[TBL] [Abstract][Full Text] [Related]
7. A "one stop liver shop" approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model.
Hla TK; Bukulatjpi SM; Binks P; Gurruwiwi GG; Dhurrkay RG; Davies J
Int J Equity Health; 2020 May; 19(1):64. PubMed ID: 32381081
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis B--care delivery and patient knowledge in the Torres Strait region of Australia.
Preston-Thomas A; Fagan P; Nakata Y; Anderson E
Aust Fam Physician; 2013 Apr; 42(4):225-31. PubMed ID: 23550250
[TBL] [Abstract][Full Text] [Related]
11. The linguistic demography of Australians living with chronic hepatitis B.
Cowie B
Aust N Z J Public Health; 2011 Feb; 35(1):12-5. PubMed ID: 21299694
[TBL] [Abstract][Full Text] [Related]
12. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
Nguyen VT; Razali K; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2008 Jun; 23(6):922-9. PubMed ID: 17608637
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance.
MacLachlan JH; Romero N; Higgins N; Coutts R; Chan R; Stephens N; Cowie BC
Aust N Z J Public Health; 2020 Feb; 44(1):59-64. PubMed ID: 31535439
[TBL] [Abstract][Full Text] [Related]
14. Modeling Progress Toward Elimination of Hepatitis B in Australia.
McCulloch K; Romero N; MacLachlan J; Allard N; Cowie B
Hepatology; 2020 Apr; 71(4):1170-1181. PubMed ID: 31419332
[TBL] [Abstract][Full Text] [Related]
15. Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013-15.
MacLachlan J; Allard N; Carville K; Haynes K; Cowie B
Aust N Z J Public Health; 2018 Feb; 42(1):62-68. PubMed ID: 28712127
[TBL] [Abstract][Full Text] [Related]
16. Cost of treating chronic hepatitis B: comparison of current treatment guidelines.
Robotin M; Patton Y; Kansil M; Penman A; George J
World J Gastroenterol; 2012 Nov; 18(42):6106-13. PubMed ID: 23155339
[TBL] [Abstract][Full Text] [Related]
17. Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective.
Wallace J; Hajarizadeh B; Richmond J; McNally S
Aust N Z J Public Health; 2013 Oct; 37(5):405-10. PubMed ID: 24090321
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
Thornley S; Bullen C; Roberts M
J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B prevalence in Australian Aboriginal and Torres Strait Islander people before and after implementing a universal vaccination program: a systematic review and meta-analysis.
Graham S; MacLachlan JH; Gunaratnam P; Cowie BC
Sex Health; 2019 Jun; 16(3):201-211. PubMed ID: 31141676
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis B in remote, tropical Australia; successes and challenges.
Hanson J; Fox M; Anderson A; Fox P; Webster K; Williams C; Nield B; Bagshaw R; Hempenstall A; Smith S; Solomon N; Boyd P
PLoS One; 2020; 15(9):e0238719. PubMed ID: 32881958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
